M. Bret Schneider
Corporate Officer/Principal bij Stanford University
Profiel
M.
Bret Schneider was the founder of Cervel Neurotech, Inc. which was founded in 2008 where he held the title of Chief Medical Officer.
Currently, he is a Staff Scientist at Stanford University.
Dr. Schneider received his undergraduate degree from Washington University in St. Louis and his doctorate from Rush University.
Actieve functies van M. Bret Schneider
Bedrijven | Functie | Begin |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
Eerdere bekende functies van M. Bret Schneider
Bedrijven | Functie | Einde |
---|---|---|
Cervel Neurotech, Inc.
Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Founder | - |
Opleiding van M. Bret Schneider
Washington University in St. Louis | Undergraduate Degree |
Rush University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Cervel Neurotech, Inc.
Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Health Technology |